- Home
- KROS vs FMNB Comparison
KROS vs FMNB Comparison
Compare KROS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | FMNB |
|---|---|---|
| Founded | 2015 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 555.3M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KROS | FMNB |
|---|---|---|
| Price | $11.02 | $12.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $22.25 | $14.33 |
| AVG Volume (30 Days) | 376.7K | ★ 446.4K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.49% |
| EPS Growth | ★ 146.00 | 18.85 |
| EPS | ★ 2.30 | 1.45 |
| Revenue | $243,864,000.00 | ★ $279,922,000.00 |
| Revenue This Year | N/A | $52.63 |
| Revenue Next Year | N/A | $8.28 |
| P/E Ratio | ★ $4.78 | $8.54 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $9.12 | $11.58 |
| 52 Week High | $22.55 | $15.50 |
Technical Indicators
Market Signals| Indicator | KROS | FMNB |
|---|---|---|
| Relative Strength Index (RSI) | 17.12 | 39.11 |
| Support Level | N/A | N/A |
| Resistance Level | $15.21 | $13.68 |
| Average True Range (ATR) | 0.71 | 0.40 |
| MACD | -0.22 | -0.07 |
| Stochastic Oscillator | 7.37 | 13.85 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.